Ikena Oncology (IKNA) Earnings Date & Reports

Ikena Oncology Inc is a targeted oncology company developing precision therapies for patients in need that target nodes of cancer growth, spread, and therapeutic resistance in the Hippo and RAS onco-signaling network... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

IKNA is expected to report earnings to fall 16.65% to -14 cents per share on August 07

Ikena Oncology IKNA Stock Earnings Reports

Q2'25

Est.

$-0.14

Q1'25

Beat

by $0.02

Q4'24

Beat

by $0.01

Q3'24

Beat

by $0.04

Q2'24

Beat

by $0.08

The last earnings report on May 08 showed earnings per share of -17 cents, beating the estimate of -19 cents. With 6.58K shares outstanding, the current market capitalization sits at 64.67M.

View a ticker or compare two or three

Compare

IKNA